Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -20.00% | +33.33% | -20.00% |
Business Summary
Number of employees: 12
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100.0
%
| 0 | 17.6 % | 0 | 100.0 % | +5.01% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -81.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 12-12-31 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 16-07-21 |
Andre Mbeng
AUD | Comptroller/Controller/Auditor | 45 | 20-10-31 |
Grant Larsen
PRN | Corporate Officer/Principal | - | 20-08-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-02-14 |
Director/Board Member | 54 | 14-12-17 | |
Anne Stevens
FOU | Founder | - | 12-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,634,431 | 113,163,965 ( 85.32 %) | 0 | 85.32 % |
Company contact information
Aequus Pharmaceuticals, Inc.
200 Granville Street Suite 2820
V6C 1S4, Vancouver
+604 336 7906
http://www.aequuspharma.caSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-20.00% | 2.42M | |
+29.61% | 682B | |
+30.35% | 586B | |
-3.62% | 364B | |
+17.71% | 327B | |
+3.85% | 285B | |
+15.74% | 240B | |
+10.32% | 209B | |
-8.38% | 203B | |
+7.12% | 165B |
- Stock Market
- Equities
- AQS Stock
- Company Aequus Pharmaceuticals Inc.